Human Immunodeficiency Virus and Liver Transplantation: Our Point of View

Transplantation Proceedings

Volumn 40, Issue 6, 2008, Pages 1965-1971

  Di Benedetto, F ^a   Di Sandro, S ^a   De Ruvo, N ^a   Berretta, M ^b   Montalti, R ^a   Guerrini, G P ^a   Ballarin, R ^a   De Blasiis, M G ^a   Spaggiari, M ^a   Smerieri, N ^a   Iemmolo, R M ^a   Guaraldi, G ^a   Gerunda, G E ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPHOTERICIN B; AMPICILLIN; AMPRENAVIR PHOSPHATE; ATAZANAVIR; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; CYCLOSPORIN A; EMTRICITABINE; ENFUVIRTIDE; FLUCONAZOLE; GANCICLOVIR; LAMIVUDINE; LOPINAVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NELFINAVIR; PEGINTERFERON; RANITIDINE; RAPAMYCIN; RIBAVIRIN; RITONAVIR; STEROID; TACROLIMUS; TENOFOVIR; VALGANCICLOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MIXED INFECTION; MONOTHERAPY; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; ALPHA-FETOPROTEINS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SARCOMA, KAPOSI; TISSUE DONORS;

EID: 48049084797     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.067     Document Type: Article

References (31)

1. Palella Jr. F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853
2. Autran B., Carcelain G., Li T.S., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112
3. Eyster M.E., Diamondstone L.S., Lien J.M., et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 6 (1993) 602
4. Darby S.C., Ewart D.W., Giangrande P.L., et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 350 (1997) 1425
5. Di Martino V., Rufat P., Boyer N., et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 34 (2001) 1193
6. Steffen T., Blattler R., Gutzwiller F., et al. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. Eur J Public Health 11 (2001) 425
7. Sherman K.E., Rouster S.D., Chung R.T., et al. Hepatitis C virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 34 (2002) 831 (Epub Feb 6, 2002)
8. th Conference of the Infectious Diseases Society of America Annual Meeting, Philadelphia, PA, November 18-21
9. Soriano V., Garcia-Samaniego J., Gutierrez M., et al. High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain. J Infect 28 (1994) 100
10. Fauci A.S., Schnittman S.M., Poli G., et al. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 114 (1991) 678
11. Di Benedetto F., De Ruvo N., Berretta M., et al. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol 24 (2006) 26
12. Ragni M.V., Dodson S.F., Hunt S.C., et al. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood 93 (1999) 1113
13. Ragni M.V., Bontempo F.A., and Lewis J.H. Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med 322 (1990) 1886
14. Spital A. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation?. The views of U.S. transplant centers. Transplantation 65 (1998) 1187
15. Sheikh A.M., Wolf D.C., Lebovics E., et al. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation 68 (1999) 307
16. Schvarcz R., Rudbeck G., Soderdahl G., et al. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation 69 (2000) 2194
17. Prachalias A.A., Pozniak A., Taylor C., et al. Liver transplantation in adults coinfected with HIV. Transplantation 72 (2001) 1684
18. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
19. Castro K.G., Ward J.W., Slutsker L., et al. 1993 revised classification system for HIV infection and expanded surveillance case definition or AIDS among adolescents and adults. MMWR 41 (1992) 1
20. O'Leary J.G., and Chung R.T. Management of hepatitis C virus coinfection in HIV-infected persons. AIDS Read 16 (2006) 313 318
21. Neff G.W., Bonham A., Tzakis A.G., et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 9 (2003) 239
22. Duclos-Vallee J.C., Vittecoq D., Teicher E., et al. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol 42 (2005) 341
23. th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February 8-11
24. Samuel D., Duclos Vallee J.C., Teicher E., et al. Liver transplantation in patients with HIV infection. J Hepatol 39 (2003) 3
25. Ragni M.V., Belle S.H., Im K., et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 188 (2003) 1412 (Epub Nov 12, 2003)
26. Jain A.K., Venkataramanan R., Shapiro R., et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 8 (2002) 841
27. Schvarcz R., Rudbeck G., Soderdahl G., et al. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation 69 (2000) 2194
28. Tseng A., Nguyen M.E., Cardella C., et al. Probable interaction between efavirenz and cyclosporine. AIDS 16 (2002) 505
29. Hossain M.M., Coull J.J., Drusano G.L., et al. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Res 55 (2002) 41
30. Moreno S., Fortun J., Quereda C., et al. Liver transplantation in HIV-infected recipients. Liver Transpl 11 (2005) 76
31. Vogel M., Voigt E., Schafer N., et al. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort. Liver Transpl 11 (2005) 1515